SELLAS Life Sciences Group (SLS) Operating Expenses: 2010-2023
Historic Operating Expenses for SELLAS Life Sciences Group (SLS) over the last 9 years, with Dec 2023 value amounting to $37.9 million.
- SELLAS Life Sciences Group's Operating Expenses fell 13.43% to $8.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was $37.9 million, marking a year-over-year decrease of 11.83%. This contributed to the annual value of $37.9 million for FY2023, which is 11.83% down from last year.
- SELLAS Life Sciences Group's Operating Expenses amounted to $37.9 million in FY2023, which was down 11.83% from $43.0 million recorded in FY2022.
- SELLAS Life Sciences Group's Operating Expenses' 5-year high stood at $43.0 million during FY2022, with a 5-year trough of $18.9 million in FY2020.
- Its 3-year average for Operating Expenses is $37.9 million, with a median of $37.9 million in 2023.
- In the last 5 years, SELLAS Life Sciences Group's Operating Expenses surged by 74.21% in 2021 and then decreased by 11.83% in 2023.
- Over the past 5 years, SELLAS Life Sciences Group's Operating Expenses (Yearly) stood at $20.0 million in 2019, then dropped by 5.78% to $18.9 million in 2020, then skyrocketed by 74.21% to $32.9 million in 2021, then skyrocketed by 30.57% to $43.0 million in 2022, then dropped by 11.83% to $37.9 million in 2023.